Faruqi & Faruqi Appointed Sole Lead Counsel to Represent Shareholders in the Ampio Pharmaceuticals Securities Class Action
Faruqi & Faruqi Appointed Sole Lead Counsel to Represent Shareholders in the Ampio Pharmaceuticals Securities Class Action
On August 9, 2023, United States District Judge William J. Martinez of the District of Colorado appointed Faruqi & Faruqi, LLP, as lead counsel in Christopher Kain v. Ampio Pharmaceuticals, Inc., et. al., 22-cv-2105-WJM-MEH. The suit centers on false and misleading statements made by Ampio Pharmaceuticals, Inc., and Individual Defendants related to its lead product candidate, Ampion.
For further inquiries regarding this matter, please contact James M. Wilson, Jr. at jwilson@faruqilaw.com or (212) 983-9330.
A copy of the Court’s order is linked below.
Documents
Ampio-Order-Granting-LPM.pdf
View PDF